Stay updated on Single Dose GHB16L2 Trivalent Influenza Vaccine Clinical Trial
Sign up to get notified when there's something new on the Single Dose GHB16L2 Trivalent Influenza Vaccine Clinical Trial page.

Latest updates to the Single Dose GHB16L2 Trivalent Influenza Vaccine Clinical Trial page
- Check2 days agoChange DetectedA notice announces NIH’s terminology transition, saying federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” under Executive Order 14434.SummaryDifference1%

- Check9 days agoChange DetectedThe footer revision label updates from v3.7.1 to v3.7.2 while the page continues to display a 403 error.SummaryDifference0.2%

- Check16 days agoChange DetectedThe site footer revision changes from v3.7.0 to v3.7.1; the study record page still displays a 403 error.SummaryDifference0.2%

- Check23 days agoChange DetectedA 403 Forbidden message appears in the study record area, with a Home link, instead of the expected study content.SummaryDifference0.5%

- Check30 days agoChange DetectedMeSH terms, sponsor/organization entries, and several study history labels were removed. The core study description and enrollment-related information appear unchanged, leaving the essential study content largely intact.SummaryDifference17%

- Check37 days agoChange DetectedRevision: v3.7.0 is now displayed in the page footer, replacing v3.6.6. This reflects a routine software/website version update and does not change the study details or how users interact with the page.SummaryDifference0.1%

Stay in the know with updates to Single Dose GHB16L2 Trivalent Influenza Vaccine Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Single Dose GHB16L2 Trivalent Influenza Vaccine Clinical Trial page.